Remote Monitoring and Support for Patients With Schizophrenia, Schizoaffective or Bipolar Disorder on Adherence

Assuta Hospital Systems

Status: Unknown

Conditions: Schizophrenia; Bipolar Disorder; Schizoaffective Disorder

Treatments: Behavioral: treatment as usual; Behavioral: intervention for improvement of adherence

Study type: Interventional

Funder types: Other

Identifiers

NCT02665611

2124-15-SMC

Details and patient eligibility

About

Moma call center will provide unique service -Remote monitoring and support for mental health patients .The aim of this reserch is reducing hospitalization and improve adherence, by reaching out and there for monitoring very closely .

Full description

"Moma" call center is a result of collaboration between Maccabi Health Services and The Gertner Institute of Epidemiology and Health Policy Research. The call center provides remote continuous monitoring and support for patients with chronic illnesses, and has been found useful for improvement in treatment adherence and other clinical measures in patients with diabetes and CHF.

The current project focuses on patients diagnosed with schizophrenia, schizoaffective disorder and bipolar disorder. Patients that suffer from these disorders are prone to low adherence and are at risk for discontinuation of treatment and frequent relapses.

The advantages of the "Moma" call-center include high availability, reaching out, collaboration between treatment centers and agents, and continuous remote monitoring. We hypothesize that these factors will enable improvement of support provided to these patients, early detection of their needs, connection with community care agents, monitoring of treatment adherence, and remote interventions targeted towards prevention of relapse.

Enrollment: 300 estimated patients

Sex: All

Ages: 18 to 60 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

Men & women,

1. age 18-60 ,
2. "Maccabi Health service" patients with diagnosis of: schizophrenia, Schizo - effective or Bipolar Dis.
3. Must have 30 days or more of hospitalization (during 3 years). Treated with psychiatric medication.
4. Living independently or with a help of a caregiver.
5. Is able to provide written informed consent.

Exclusion criteria

1. Violent, or suicidal.
2. Drug\ Alcohol, addiction,
3. End stage Disease (Cancer, ESRF act.)
4. Non - in depended and without Care giver/legal guardian

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

300 participants in 2 patient groups

intervention group

Experimental group

Description:

intervention for improvement of treatment adherence "Intervention group"- This group will be followed by the "MOMA" call center (By the MOMA nures every couple weeks and by the study coordinatore and the treating Doctor at special "visits" as the study required.) The group will be monitored according to number of parameters, including treatment Adherence.

Treatment:

Behavioral: intervention for improvement of adherence

control group

Experimental group

Description:

treatment as usual Control group- Treatment will continue as usual by the Doctor.(This group will allso be followed by the Study Coordinator at the same "visits" as the "Intervention group".The group will be monitored according to number of parameters, including treatment Adherence.

Treatment:

Behavioral: treatment as usual